FDA Drug Application (205449) for MILI by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number205449
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG;0.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMILI
Active IngredientETHINYL ESTRADIOL; NORGESTIMATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORGESTIMATE23


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD